Two Sigma Investments’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-378,695
Closed -$4.15M 3462
2017
Q2
$4.15M Sell
378,695
-67,627
-15% -$742K 0.02% 962
2017
Q1
$4.71M Buy
446,322
+208,610
+88% +$2.02M 0.02% 965
2016
Q4
$2M Buy
237,712
+78,643
+49% +$616K 0.01% 1491
2016
Q3
$1.14M Buy
159,069
+95,524
+150% +$664K ﹤0.01% 1866
2016
Q2
$489K Buy
63,545
+18,375
+41% +$131K ﹤0.01% 2266
2016
Q1
$330K Sell
45,170
-4,062
-8% -$29.1K ﹤0.01% 2330
2015
Q4
$380K Sell
49,232
-93,326
-65% -$712K ﹤0.01% 2123
2015
Q3
$1.02M Sell
142,558
-38,620
-21% -$371K 0.01% 1184
2015
Q2
$1.92M Sell
181,178
-60,353
-25% -$707K 0.01% 1231
2015
Q1
$2.99M Buy
241,531
+162,562
+206% +$1.8M 0.01% 954
2014
Q4
$737K Buy
78,969
+12,516
+19% +$121K ﹤0.01% 1519
2014
Q3
$666K Sell
66,453
-11,839
-15% -$120K ﹤0.01% 1204
2014
Q2
$808K Sell
78,292
-22,661
-22% -$245K ﹤0.01% 1414
2014
Q1
$1.26M Buy
100,953
+48,864
+94% +$579K 0.01% 1113
2013
Q4
$640K Buy
52,089
+40,067
+333% +$416K ﹤0.01% 1558
2013
Q3
$103K Sell
12,022
-54,200
-82% -$468K ﹤0.01% 1743
2013
Q2
$576K Buy
+66,222
New +$592K ﹤0.01% 1342

Other funds holding ELOS

Two Sigma Investments's ELOS Position: Q3 2017 in Review

Two Sigma Investments sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 378,695 shares — an estimated $4.15M sold.

Two Sigma Investments first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $4.71M in Q1 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Two Sigma Investments reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Two Sigma Investments sold 378,695 Syneron Medical Ltd shares in Q3 2017, an estimated $4.15M.
  • Two Sigma Investments first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Two Sigma Investments's Syneron Medical Ltd position peaked at $4.71M in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Two Sigma Investments's 13F filing for Q3 2017, filed 14 Nov 2017.